← Open Payments lookup

TRACY HICKS: Open Payments

NPI 1215353651 · LONGVIEW, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$269,985 in 445 payments from 14 companies in 2025. Trend: 2023 $102,500 · 2024 $200,299 · 2025 $269,985

Speaker / faculty: $187,774Consulting: $42,645Travel & lodging: $29,182Food & beverage: $10,384
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.170$128,675
Neurocrine BioSciences, Inc.106$64,297
Teva Pharmaceuticals USA, Inc.73$48,482
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)29$19,904
Alkermes, Inc.26$7,823
Vanda Pharmaceuticals Inc.10$218
ABBVIE INC.13$135
ARS Pharmaceuticals Operations, Inc.1$126
Otsuka America Pharmaceutical, Inc.6$114
Indivior Inc.4$74

Products named: COBENFY, INGREZZA, UZEDY, CAPLYTA, AUSTEDO XR, LYBALVI, ARISTADA, FANAPT.

Industry payments across TX — which companies pay providers there.